Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis

Abstract Background The aim of this study was to estimate the efficacy and safety of bevacizumab combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in advanced non‐small cell lung cancer (NSCLC) patients. Methods We searched randomized controlled trials (RCTs) on b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yifan Yang, Liming Wang, Xu Li, Shuai Zhang, Jiangyong Yu, Xin Nie, Wenbo Liu, Xiaonan Wu, Ping Zhang, Yi Li, Ailing Li, Bin Ai
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-01-01
Colecção:Thoracic Cancer
Assuntos:
bevacizumab
cancer
EGFR‐TKI
meta‐analysis
NSCLC
Acesso em linha:https://doi.org/10.1111/1759-7714.14214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados